Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)

CUSIP: 90400D108

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / Common Stock
Shares outstanding
98,367,418
Total 13F shares
15,678,184
Share change
+15,678,184
Total reported value
$746,820,000
Price per share
$48.89
Number of holders
77
Value change
+$746,820,000
Number of buys
77

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) as of Q1 2014

As of 31 Mar 2014, Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,678,184 shares. The largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, ADAGE CAPITAL PARTNERS GP LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT CO LLP, Visium Asset Management, LP, Capital World Investors, FMR LLC, and JENNISON ASSOCIATES LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2014 vs Q4 2025 Across Filers

Q4 2025 holders
284
Q1 2014 holders
77
Holder diff
-207
Investor Q4 2025 Shares Q1 2014 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .